Crewe Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7K | Hold |
250
| – | – | ﹤0.01% | 422 |
|
|
2025
Q1 | $17.7K | Hold |
250
| – | – | ﹤0.01% | 361 |
|
|
2024
Q4 | $16.4K | Hold |
250
| – | – | ﹤0.01% | 376 |
|
|
2024
Q3 | $17.6K | Hold |
250
| – | – | ﹤0.01% | 417 |
|
|
2024
Q2 | $20.6K | Hold |
250
| – | – | ﹤0.01% | 547 |
|
|
2024
Q1 | $21.8K | Buy |
+250
| New | +$21.8K | ﹤0.01% | 478 |
|
|
2023
Q2 | – | Sell |
-126
| Closed | -$12.3K | – | 891 |
|
|
2023
Q1 | $12.3K | Hold |
126
| – | – | ﹤0.01% | 508 |
|
|
2022
Q4 | $13K | Sell |
126
-74
| -37% | -$7.66K | ﹤0.01% | 497 |
|
|
2022
Q3 | $17K | Buy |
200
+30
| +18% | +$2.55K | ﹤0.01% | 500 |
|
|
2022
Q2 | $14K | Buy |
+170
| New | +$14K | ﹤0.01% | 508 |
|
|
2020
Q4 | – | Sell |
-15
| Closed | -$1K | – | 470 |
|
|
2020
Q3 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 558 |
|